Among insured patients with type 2 diabetes, copayments and glycosylated hemoglobin values were associated with increased rates of drug switching.
Rosanne C. Harrigan, MS, EdD
Advertisement
Articles by Rosanne C. Harrigan, MS, EdD
Advertisement
Latest Updated Articles
- Copayment Level and Drug Switching: Findings for Type 2 Diabetes
Published: January 8th 2011 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Common Virus May Hold New Clues to Lupus
2
SHR-A1811 Plus Pertuzumab Improves Survival in HER2-Positive Metastatic Breast Cancer
3
FDA Approves Poherdy, First Biosimilar to Perjeta, For HER2 Breast Cancer Indications
4
When to Call, When to Counsel: Statin Drug Interactions
5
